ETF Afternoon Review | The sector of innovative drugs in the Hong Kong stock market leads the rise, with the Hang Seng Innovative Drugs Industry ETF up 4.35%, while the Huaan CES HK Equities Selected 100 ETF and the Huaan CES HK Equities 50 ETF hit the li

On April 22, according to Glory Exchange, the three major A-share indices showed mixed performance in the morning. By lunchtime, the Shanghai Composite Index rose by 0.31%, the Shenzhen Component Index fell by 0.41%, the Chinext Price Index decreased by 0.98%, and the Northbound 50 Index was down 0.15%. The total trading volume of the All Market in half a day reached 712.6 billion yuan, an increase of 63.9 billion yuan compared to the previous day. Over 3,100 stocks in the All Market saw declines. In terms of sectors, Logistics, Supply and Marketing Cooperatives, Cross-Border Payment, Unified National Market, and Autos saw the largest gains; Tourism and Hotels, Movie Theater Line, Computing Power, and Liquid Cooling Server concepts had the largest declines. In terms of ETFs, the Hong Kong stock innovative drug sector strengthened, with E Fund HENGSHENGETF, Huatai-PB HENGSHENGETF, and Yinhua HKG Innovative Drug ETF rising by 4.35%, 4.23%, and 4.12% respectively. During Tuesday’s Asian trading session, spot gold broke through multiple levels consecutively, while the Fobon Fund Gold ETF, ChinaAMC Gold ETF, and CCB Principal Shanghai Gold ETF rose by 3.98%, 3.83%, and 3.81% respectively. During the market closure for Hong Kong stocks, the premiums of the China Merchants SSE HK Equities ETF increased, while today the China Merchants SSE HK Equities Selected 100 ETF and China Merchants SSE HK Equities 50 ETF fell to their limit, and HENGSHENGETF decreased by 9.38%, with the latest premium/discount ratios at 7.94%, 3.26%, and -0.03% respectively. The film sector declined, with Movie Theater Line ETF dropping by 2.43%.